Maravai Lifesciences Holdings (MRVI) Stock Research

Maravai Lifesciences Holdings

· MRVI

Dashboard

Financials

KPIs

Ratios

Transcripts

Valuation

Statistics

1.987 B

+0.13%

Yesterday

Maravai Lifesciences' TriLink BioTechnologies secures CleanCap China patent

MRVI

Yesterday, 4:02 PM

Over a week ago

Maravai Lifesciences initiated with neutral view at UBS, here's why

MRVI

Sep 9, 7:28 AM

Stifel sees Moderna data as positive for Repligen, Maravai

Aug 19, 9:07 AM

Wells sees Repligen among key beneficiaries of Moderna's cancer vaccine data

Aug 19, 9:02 AM

Closing Bell Movers: Doximity soars after quarterly report

+17

Aug 6, 6:46 PM

Maravai Lifesciences sees FY26 revenue $205M-$215M, consensus $208.6M

MRVI

Aug 6, 4:05 PM

Maravai Lifesciences reports Q2 EPS (8c), consensus (4c)

MRVI

Aug 6, 4:04 PM

Maravai's TrinLink BioTechnologies granted new patent in China

MRVI

Jul 20, 4:04 PM

Maravai Lifesciences announces opening of GMP enzyme manufacturing facility

MRVI

Jun 16, 8:34 AM

Maravai Lifesciences announces refinancing of credit agreement

MRVI

Jun 3, 8:32 AM

Maravai Lifesciences price target raised by $1.50 at Deutsche Bank

MRVI

May 8, 8:53 AM

Maravai Lifesciences sees FY26 revenue $205M-$215M, consensus $204.9M

MRVI

May 7, 4:30 PM

Maravai Lifesciences reports Q1 EPS 1c, consensus (5c)

MRVI

May 7, 4:30 PM

Maravai Lifesciences price target raised by $1 at Baird, here's why

MRVI

Feb 26, 10:18 AM

Maravai Lifesciences sees FY26 revenue $200M-$210M, consensus $203.26M

MRVI

Feb 25, 4:05 PM

Maravai Lifesciences reports Q4 adjusted EPS (4c), consensus (7c)

MRVI

Feb 25, 4:05 PM

Maravai Lifesciences price target raised by 50c at Wells Fargo, here's why

MRVI

Dec 15, 6:28 AM

Maravai Lifesciences director buys $368.5K in common stock

MRVI

Dec 9, 5:03 PM

Closing Bell Movers: Inotiv surges after quarterly results

Nov 17, 6:51 PM

Maravai Lifesciences CEO buys $702.7K of class A shares

MRVI

Nov 17, 6:36 PM

Maravai Lifesciences price target lowered by $1 at Stifel, here's why

MRVI

Nov 7, 10:47 AM

Maravai Lifesciences reports Q3 adjusted EPS (8c), consensus (8c)

MRVI

Nov 6, 4:02 PM

No more stories

Charts

Yesterday

Maravai Lifesciences' TriLink BioTechnologies secures CleanCap China patent

MRVI

Yesterday, 4:02 PM

Over a week ago

Maravai Lifesciences initiated with neutral view at UBS, here's why

MRVI

Sep 9, 7:28 AM

Stifel sees Moderna data as positive for Repligen, Maravai

Aug 19, 9:07 AM

Wells sees Repligen among key beneficiaries of Moderna's cancer vaccine data

Aug 19, 9:02 AM

Closing Bell Movers: Doximity soars after quarterly report

+17

Aug 6, 6:46 PM

Maravai Lifesciences sees FY26 revenue $205M-$215M, consensus $208.6M

MRVI

Aug 6, 4:05 PM

Maravai Lifesciences reports Q2 EPS (8c), consensus (4c)

MRVI

Aug 6, 4:04 PM

Maravai's TrinLink BioTechnologies granted new patent in China

MRVI

Jul 20, 4:04 PM

Maravai Lifesciences announces opening of GMP enzyme manufacturing facility

MRVI

Jun 16, 8:34 AM

Maravai Lifesciences announces refinancing of credit agreement

MRVI

Jun 3, 8:32 AM

Maravai Lifesciences price target raised by $1.50 at Deutsche Bank

MRVI

May 8, 8:53 AM

Maravai Lifesciences sees FY26 revenue $205M-$215M, consensus $204.9M

MRVI

May 7, 4:30 PM

Maravai Lifesciences reports Q1 EPS 1c, consensus (5c)

MRVI

May 7, 4:30 PM

Maravai Lifesciences price target raised by $1 at Baird, here's why

MRVI

Feb 26, 10:18 AM

Maravai Lifesciences sees FY26 revenue $200M-$210M, consensus $203.26M

MRVI

Feb 25, 4:05 PM

Maravai Lifesciences reports Q4 adjusted EPS (4c), consensus (7c)

MRVI

Feb 25, 4:05 PM

Maravai Lifesciences price target raised by 50c at Wells Fargo, here's why

MRVI

Dec 15, 6:28 AM

Maravai Lifesciences director buys $368.5K in common stock

MRVI

Dec 9, 5:03 PM

Closing Bell Movers: Inotiv surges after quarterly results

Nov 17, 6:51 PM

Maravai Lifesciences CEO buys $702.7K of class A shares

MRVI

Nov 17, 6:36 PM

Maravai Lifesciences price target lowered by $1 at Stifel, here's why

MRVI

Nov 7, 10:47 AM

Maravai Lifesciences reports Q3 adjusted EPS (8c), consensus (8c)

MRVI

Nov 6, 4:02 PM

No more stories

Company News

Charts